Industry Research Reports

Home > Reports > Chemical & Material > Global NSAID API Market Insights, Forecast to 2030

Global NSAID API Market Insights, Forecast to 2030

Industry: Chemical & Material

Published Date: 2024-04-22

Pages: 109 Pages

Report ld: 3042669

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Active pharmaceutical ingredients (APIs) are bulk drug products that are used as raw materials for formulations. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that groups together drugs that provide analgesic (pain-killing) and antipyretic (fever-reducing) effects, and, in higher doses, anti-inflammatory effects.

The global NSAID API market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

North America dominated the global NSAID API market due to high demand for APIs in drug formulations and research and development programs in this region. The region is expected to continue its dominance in the coming years owing to increasing preference for generic medicines as a result of high healthcare costs in the U.S. Among other regions, Asia-Pacific is the next largest market for APIs. This region has become the most attractive market due to clustering of a large number of generic medicine manufacturers.

In terms of production side, this report researches the NSAID API production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.

In terms of consumption side, this report focuses on the sales of NSAID API by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.

Report Covers:

This report presents an overview of global market for NSAID API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of NSAID API, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for NSAID API, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the NSAID API sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global NSAID API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for NSAID API sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Novartis, Pfizer, Boehringer Ingelheim, Teva Pharmaceutical, BASF, Hospira, Lonza Group, Mylan and Aurobindo Pharma, etc.

MARKET SEGMENTATION

By Company

Novartis
Pfizer
Boehringer Ingelheim
Teva Pharmaceutical
BASF
Hospira
Lonza Group
Mylan
Aurobindo Pharma
Cambrex
Dr. Reddy's Laboratories
Actavis
Wuxi Apptec
Zhejiang NHU

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Paracetamol
Ibuprofen
Aspirin
Naproxen
Others

Segment by Application

Captive Manufacturing
Contract Manufacturing

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: NSAID API production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 3: Sales (consumption), revenue of NSAID API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of NSAID API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 9: China by Type, and by Application, sales, and revenue for each segment.

Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, NSAID API sales, revenue, price, gross margin, and recent development, etc.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 15: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 NSAID API Product Introduction

1.2 Market by Type

1.2.1 Global NSAID API Market Size by Type, 2019 VS 2023 VS 2030

1.2.2 Paracetamol

1.2.3 Ibuprofen

1.2.4 Aspirin

1.2.5 Naproxen

1.2.6 Others

1.3 Market by Application

1.3.1 Global NSAID API Market Size by Application, 2019 VS 2023 VS 2030

1.3.2 Captive Manufacturing

1.3.3 Contract Manufacturing

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global NSAID API Production

2.1 Global NSAID API Production Capacity (2019-2030)

2.2 Global NSAID API Production by Region: 2019 VS 2023 VS 2030

2.3 Global NSAID API Production by Region

2.3.1 Global NSAID API Historic Production by Region (2019-2024)

2.3.2 Global NSAID API Forecasted Production by Region (2025-2030)

2.3.3 Global NSAID API Production Market Share by Region (2019-2030)

2.4 North America

2.5 Europe

2.6 China

2.7 Japan

3 Executive Summary

3.1 Global NSAID API Revenue Estimates and Forecasts 2019-2030

3.2 Global NSAID API Revenue by Region

3.2.1 Global NSAID API Revenue by Region: 2019 VS 2023 VS 2030

3.2.2 Global NSAID API Revenue by Region (2019-2024)

3.2.3 Global NSAID API Revenue by Region (2025-2030)

3.2.4 Global NSAID API Revenue Market Share by Region (2019-2030)

3.3 Global NSAID API Sales Estimates and Forecasts 2019-2030

3.4 Global NSAID API Sales by Region

3.4.1 Global NSAID API Sales by Region: 2019 VS 2023 VS 2030

3.4.2 Global NSAID API Sales by Region (2019-2024)

3.4.3 Global NSAID API Sales by Region (2025-2030)

3.4.4 Global NSAID API Sales Market Share by Region (2019-2030)

3.5 US & Canada

3.6 Europe

3.7 China

3.8 Asia (excluding China)

3.9 Middle East, Africa and Latin America

4 Competition by Manufactures

4.1 Global NSAID API Sales by Manufacturers

4.1.1 Global NSAID API Sales by Manufacturers (2019-2024)

4.1.2 Global NSAID API Sales Market Share by Manufacturers (2019-2024)

4.1.3 Global Top 10 and Top 5 Largest Manufacturers of NSAID API in 2023

4.2 Global NSAID API Revenue by Manufacturers

4.2.1 Global NSAID API Revenue by Manufacturers (2019-2024)

4.2.2 Global NSAID API Revenue Market Share by Manufacturers (2019-2024)

4.2.3 Global Top 10 and Top 5 Companies by NSAID API Revenue in 2023

4.3 Global NSAID API Sales Price by Manufacturers

4.4 Global Key Players of NSAID API, Industry Ranking, 2022 VS 2023 VS 2024

4.5 Analysis of Competitive Landscape

4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

4.5.2 Global NSAID API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.6 Global Key Manufacturers of NSAID API, Manufacturing Base Distribution and Headquarters

4.7 Global Key Manufacturers of NSAID API, Product Offered and Application

4.8 Global Key Manufacturers of NSAID API, Date of Enter into This Industry

4.9 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type

5.1 Global NSAID API Sales by Type

5.1.1 Global NSAID API Historical Sales by Type (2019-2024)

5.1.2 Global NSAID API Forecasted Sales by Type (2025-2030)

5.1.3 Global NSAID API Sales Market Share by Type (2019-2030)

5.2 Global NSAID API Revenue by Type

5.2.1 Global NSAID API Historical Revenue by Type (2019-2024)

5.2.2 Global NSAID API Forecasted Revenue by Type (2025-2030)

5.2.3 Global NSAID API Revenue Market Share by Type (2019-2030)

5.3 Global NSAID API Price by Type

5.3.1 Global NSAID API Price by Type (2019-2024)

5.3.2 Global NSAID API Price Forecast by Type (2025-2030)

6 Market Size by Application

6.1 Global NSAID API Sales by Application

6.1.1 Global NSAID API Historical Sales by Application (2019-2024)

6.1.2 Global NSAID API Forecasted Sales by Application (2025-2030)

6.1.3 Global NSAID API Sales Market Share by Application (2019-2030)

6.2 Global NSAID API Revenue by Application

6.2.1 Global NSAID API Historical Revenue by Application (2019-2024)

6.2.2 Global NSAID API Forecasted Revenue by Application (2025-2030)

6.2.3 Global NSAID API Revenue Market Share by Application (2019-2030)

6.3 Global NSAID API Price by Application

6.3.1 Global NSAID API Price by Application (2019-2024)

6.3.2 Global NSAID API Price Forecast by Application (2025-2030)

7 US & Canada

7.1 US & Canada NSAID API Market Size by Type

7.1.1 US & Canada NSAID API Sales by Type (2019-2030)

7.1.2 US & Canada NSAID API Revenue by Type (2019-2030)

7.2 US & Canada NSAID API Market Size by Application

7.2.1 US & Canada NSAID API Sales by Application (2019-2030)

7.2.2 US & Canada NSAID API Revenue by Application (2019-2030)

7.3 US & Canada NSAID API Sales by Country

7.3.1 US & Canada NSAID API Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 US & Canada NSAID API Sales by Country (2019-2030)

7.3.3 US & Canada NSAID API Revenue by Country (2019-2030)

7.3.4 U.S.

7.3.5 Canada

8 Europe

8.1 Europe NSAID API Market Size by Type

8.1.1 Europe NSAID API Sales by Type (2019-2030)

8.1.2 Europe NSAID API Revenue by Type (2019-2030)

8.2 Europe NSAID API Market Size by Application

8.2.1 Europe NSAID API Sales by Application (2019-2030)

8.2.2 Europe NSAID API Revenue by Application (2019-2030)

8.3 Europe NSAID API Sales by Country

8.3.1 Europe NSAID API Revenue by Country: 2019 VS 2023 VS 2030

8.3.2 Europe NSAID API Sales by Country (2019-2030)

8.3.3 Europe NSAID API Revenue by Country (2019-2030)

8.3.4 Germany

8.3.5 France

8.3.6 U.K.

8.3.7 Italy

8.3.8 Russia

9 China

9.1 China NSAID API Market Size by Type

9.1.1 China NSAID API Sales by Type (2019-2030)

9.1.2 China NSAID API Revenue by Type (2019-2030)

9.2 China NSAID API Market Size by Application

9.2.1 China NSAID API Sales by Application (2019-2030)

9.2.2 China NSAID API Revenue by Application (2019-2030)

10 Asia (excluding China)

10.1 Asia NSAID API Market Size by Type

10.1.1 Asia NSAID API Sales by Type (2019-2030)

10.1.2 Asia NSAID API Revenue by Type (2019-2030)

10.2 Asia NSAID API Market Size by Application

10.2.1 Asia NSAID API Sales by Application (2019-2030)

10.2.2 Asia NSAID API Revenue by Application (2019-2030)

10.3 Asia NSAID API Sales by Region

10.3.1 Asia NSAID API Revenue by Region: 2019 VS 2023 VS 2030

10.3.2 Asia NSAID API Revenue by Region (2019-2030)

10.3.3 Asia NSAID API Sales by Region (2019-2030)

10.3.4 Japan

10.3.5 South Korea

10.3.6 China Taiwan

10.3.7 Southeast Asia

10.3.8 India

11 Middle East, Africa and Latin America

11.1 Middle East, Africa and Latin America NSAID API Market Size by Type

11.1.1 Middle East, Africa and Latin America NSAID API Sales by Type (2019-2030)

11.1.2 Middle East, Africa and Latin America NSAID API Revenue by Type (2019-2030)

11.2 Middle East, Africa and Latin America NSAID API Market Size by Application

11.2.1 Middle East, Africa and Latin America NSAID API Sales by Application (2019-2030)

11.2.2 Middle East, Africa and Latin America NSAID API Revenue by Application (2019-2030)

11.3 Middle East, Africa and Latin America NSAID API Sales by Country

11.3.1 Middle East, Africa and Latin America NSAID API Revenue by Country: 2019 VS 2023 VS 2030

11.3.2 Middle East, Africa and Latin America NSAID API Revenue by Country (2019-2030)

11.3.3 Middle East, Africa and Latin America NSAID API Sales by Country (2019-2030)

11.3.4 Brazil

11.3.5 Mexico

11.3.6 Turkey

11.3.7 Israel

11.3.8 GCC Countries

12 Corporate Profiles

12.1 Novartis

12.1.1 Novartis Company Information

12.1.2 Novartis Overview

12.1.3 Novartis NSAID API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.1.4 Novartis NSAID API Product Model Numbers, Pictures, Descriptions and Specifications

12.1.5 Novartis Recent Developments

12.2 Pfizer

12.2.1 Pfizer Company Information

12.2.2 Pfizer Overview

12.2.3 Pfizer NSAID API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.2.4 Pfizer NSAID API Product Model Numbers, Pictures, Descriptions and Specifications

12.2.5 Pfizer Recent Developments

12.3 Boehringer Ingelheim

12.3.1 Boehringer Ingelheim Company Information

12.3.2 Boehringer Ingelheim Overview

12.3.3 Boehringer Ingelheim NSAID API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.3.4 Boehringer Ingelheim NSAID API Product Model Numbers, Pictures, Descriptions and Specifications

12.3.5 Boehringer Ingelheim Recent Developments

12.4 Teva Pharmaceutical

12.4.1 Teva Pharmaceutical Company Information

12.4.2 Teva Pharmaceutical Overview

12.4.3 Teva Pharmaceutical NSAID API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.4.4 Teva Pharmaceutical NSAID API Product Model Numbers, Pictures, Descriptions and Specifications

12.4.5 Teva Pharmaceutical Recent Developments

12.5 BASF

12.5.1 BASF Company Information

12.5.2 BASF Overview

12.5.3 BASF NSAID API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.5.4 BASF NSAID API Product Model Numbers, Pictures, Descriptions and Specifications

12.5.5 BASF Recent Developments

12.6 Hospira

12.6.1 Hospira Company Information

12.6.2 Hospira Overview

12.6.3 Hospira NSAID API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.6.4 Hospira NSAID API Product Model Numbers, Pictures, Descriptions and Specifications

12.6.5 Hospira Recent Developments

12.7 Lonza Group

12.7.1 Lonza Group Company Information

12.7.2 Lonza Group Overview

12.7.3 Lonza Group NSAID API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.7.4 Lonza Group NSAID API Product Model Numbers, Pictures, Descriptions and Specifications

12.7.5 Lonza Group Recent Developments

12.8 Mylan

12.8.1 Mylan Company Information

12.8.2 Mylan Overview

12.8.3 Mylan NSAID API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.8.4 Mylan NSAID API Product Model Numbers, Pictures, Descriptions and Specifications

12.8.5 Mylan Recent Developments

12.9 Aurobindo Pharma

12.9.1 Aurobindo Pharma Company Information

12.9.2 Aurobindo Pharma Overview

12.9.3 Aurobindo Pharma NSAID API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.9.4 Aurobindo Pharma NSAID API Product Model Numbers, Pictures, Descriptions and Specifications

12.9.5 Aurobindo Pharma Recent Developments

12.10 Cambrex

12.10.1 Cambrex Company Information

12.10.2 Cambrex Overview

12.10.3 Cambrex NSAID API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.10.4 Cambrex NSAID API Product Model Numbers, Pictures, Descriptions and Specifications

12.10.5 Cambrex Recent Developments

12.11 Dr. Reddy's Laboratories

12.11.1 Dr. Reddy's Laboratories Company Information

12.11.2 Dr. Reddy's Laboratories Overview

12.11.3 Dr. Reddy's Laboratories NSAID API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.11.4 Dr. Reddy's Laboratories NSAID API Product Model Numbers, Pictures, Descriptions and Specifications

12.11.5 Dr. Reddy's Laboratories Recent Developments

12.12 Actavis

12.12.1 Actavis Company Information

12.12.2 Actavis Overview

12.12.3 Actavis NSAID API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.12.4 Actavis NSAID API Product Model Numbers, Pictures, Descriptions and Specifications

12.12.5 Actavis Recent Developments

12.13 Wuxi Apptec

12.13.1 Wuxi Apptec Company Information

12.13.2 Wuxi Apptec Overview

12.13.3 Wuxi Apptec NSAID API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.13.4 Wuxi Apptec NSAID API Product Model Numbers, Pictures, Descriptions and Specifications

12.13.5 Wuxi Apptec Recent Developments

12.14 Zhejiang NHU

12.14.1 Zhejiang NHU Company Information

12.14.2 Zhejiang NHU Overview

12.14.3 Zhejiang NHU NSAID API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.14.4 Zhejiang NHU NSAID API Product Model Numbers, Pictures, Descriptions and Specifications

12.14.5 Zhejiang NHU Recent Developments

13 Industry Chain and Sales Channels Analysis

13.1 NSAID API Industry Chain Analysis

13.2 NSAID API Key Raw Materials

13.2.1 Key Raw Materials

13.2.2 Raw Materials Key Suppliers

13.3 NSAID API Production Mode & Process

13.4 NSAID API Sales and Marketing

13.4.1 NSAID API Sales Channels

13.4.2 NSAID API Distributors

13.5 NSAID API Customers

14 NSAID API Market Dynamics

14.1 NSAID API Industry Trends

14.2 NSAID API Market Drivers

14.3 NSAID API Market Challenges

14.4 NSAID API Market Restraints

15 Key Finding in The Global NSAID API Study

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details

16.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global NSAID API Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Paracetamol

Table 3. Major Manufacturers of Ibuprofen

Table 4. Major Manufacturers of Aspirin

Table 5. Major Manufacturers of Naproxen

Table 6. Major Manufacturers of Others

Table 7. Global NSAID API Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global NSAID API Production by Region: 2019 VS 2023 VS 2030 (K MT)

Table 9. Global NSAID API Production by Region (2019-2024) & (K MT)

Table 10. Global NSAID API Production by Region (2025-2030) & (K MT)

Table 11. Global NSAID API Production Market Share by Region (2019-2024)

Table 12. Global NSAID API Production Market Share by Region (2025-2030)

Table 13. Global NSAID API Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global NSAID API Revenue by Region (2019-2024) & (US$ Million)

Table 15. Global NSAID API Revenue by Region (2025-2030) & (US$ Million)

Table 16. Global NSAID API Revenue Market Share by Region (2019-2024)

Table 17. Global NSAID API Revenue Market Share by Region (2025-2030)

Table 18. Global NSAID API Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global NSAID API Sales by Region (2019-2024) & (K MT)

Table 20. Global NSAID API Sales by Region (2025-2030) & (K MT)

Table 21. Global NSAID API Sales Market Share by Region (2019-2024)

Table 22. Global NSAID API Sales Market Share by Region (2025-2030)

Table 23. Global NSAID API Sales by Manufacturers (2019-2024) & (K MT)

Table 24. Global NSAID API Sales Share by Manufacturers (2019-2024)

Table 25. Global NSAID API Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 26. Global NSAID API Revenue Share by Manufacturers (2019-2024)

Table 27. NSAID API Price by Manufacturers 2019-2024 (USD/MT)

Table 28. Global Key Players of NSAID API, Industry Ranking, 2022 VS 2023 VS 2024

Table 29. Global NSAID API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 30. Global NSAID API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NSAID API as of 2023)

Table 31. Global Key Manufacturers of NSAID API, Manufacturing Base Distribution and Headquarters

Table 32. Global Key Manufacturers of NSAID API, Product Offered and Application

Table 33. Global Key Manufacturers of NSAID API, Date of Enter into This Industry

Table 34. Mergers & Acquisitions, Expansion Plans

Table 35. Global NSAID API Sales by Type (2019-2024) & (K MT)

Table 36. Global NSAID API Sales by Type (2025-2030) & (K MT)

Table 37. Global NSAID API Sales Share by Type (2019-2024)

Table 38. Global NSAID API Sales Share by Type (2025-2030)

Table 39. Global NSAID API Revenue by Type (2019-2024) & (US$ Million)

Table 40. Global NSAID API Revenue by Type (2025-2030) & (US$ Million)

Table 41. Global NSAID API Revenue Share by Type (2019-2024)

Table 42. Global NSAID API Revenue Share by Type (2025-2030)

Table 43. NSAID API Price by Type (2019-2024) & (USD/MT)

Table 44. Global NSAID API Price Forecast by Type (2025-2030) & (USD/MT)

Table 45. Global NSAID API Sales by Application (2019-2024) & (K MT)

Table 46. Global NSAID API Sales by Application (2025-2030) & (K MT)

Table 47. Global NSAID API Sales Share by Application (2019-2024)

Table 48. Global NSAID API Sales Share by Application (2025-2030)

Table 49. Global NSAID API Revenue by Application (2019-2024) & (US$ Million)

Table 50. Global NSAID API Revenue by Application (2025-2030) & (US$ Million)

Table 51. Global NSAID API Revenue Share by Application (2019-2024)

Table 52. Global NSAID API Revenue Share by Application (2025-2030)

Table 53. NSAID API Price by Application (2019-2024) & (USD/MT)

Table 54. Global NSAID API Price Forecast by Application (2025-2030) & (USD/MT)

Table 55. US & Canada NSAID API Sales by Type (2019-2024) & (K MT)

Table 56. US & Canada NSAID API Sales by Type (2025-2030) & (K MT)

Table 57. US & Canada NSAID API Revenue by Type (2019-2024) & (US$ Million)

Table 58. US & Canada NSAID API Revenue by Type (2025-2030) & (US$ Million)

Table 59. US & Canada NSAID API Sales by Application (2019-2024) & (K MT)

Table 60. US & Canada NSAID API Sales by Application (2025-2030) & (K MT)

Table 61. US & Canada NSAID API Revenue by Application (2019-2024) & (US$ Million)

Table 62. US & Canada NSAID API Revenue by Application (2025-2030) & (US$ Million)

Table 63. US & Canada NSAID API Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 64. US & Canada NSAID API Revenue by Country (2019-2024) & (US$ Million)

Table 65. US & Canada NSAID API Revenue by Country (2025-2030) & (US$ Million)

Table 66. US & Canada NSAID API Sales by Country (2019-2024) & (K MT)

Table 67. US & Canada NSAID API Sales by Country (2025-2030) & (K MT)

Table 68. Europe NSAID API Sales by Type (2019-2024) & (K MT)

Table 69. Europe NSAID API Sales by Type (2025-2030) & (K MT)

Table 70. Europe NSAID API Revenue by Type (2019-2024) & (US$ Million)

Table 71. Europe NSAID API Revenue by Type (2025-2030) & (US$ Million)

Table 72. Europe NSAID API Sales by Application (2019-2024) & (K MT)

Table 73. Europe NSAID API Sales by Application (2025-2030) & (K MT)

Table 74. Europe NSAID API Revenue by Application (2019-2024) & (US$ Million)

Table 75. Europe NSAID API Revenue by Application (2025-2030) & (US$ Million)

Table 76. Europe NSAID API Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 77. Europe NSAID API Revenue by Country (2019-2024) & (US$ Million)

Table 78. Europe NSAID API Revenue by Country (2025-2030) & (US$ Million)

Table 79. Europe NSAID API Sales by Country (2019-2024) & (K MT)

Table 80. Europe NSAID API Sales by Country (2025-2030) & (K MT)

Table 81. China NSAID API Sales by Type (2019-2024) & (K MT)

Table 82. China NSAID API Sales by Type (2025-2030) & (K MT)

Table 83. China NSAID API Revenue by Type (2019-2024) & (US$ Million)

Table 84. China NSAID API Revenue by Type (2025-2030) & (US$ Million)

Table 85. China NSAID API Sales by Application (2019-2024) & (K MT)

Table 86. China NSAID API Sales by Application (2025-2030) & (K MT)

Table 87. China NSAID API Revenue by Application (2019-2024) & (US$ Million)

Table 88. China NSAID API Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia NSAID API Sales by Type (2019-2024) & (K MT)

Table 90. Asia NSAID API Sales by Type (2025-2030) & (K MT)

Table 91. Asia NSAID API Revenue by Type (2019-2024) & (US$ Million)

Table 92. Asia NSAID API Revenue by Type (2025-2030) & (US$ Million)

Table 93. Asia NSAID API Sales by Application (2019-2024) & (K MT)

Table 94. Asia NSAID API Sales by Application (2025-2030) & (K MT)

Table 95. Asia NSAID API Revenue by Application (2019-2024) & (US$ Million)

Table 96. Asia NSAID API Revenue by Application (2025-2030) & (US$ Million)

Table 97. Asia NSAID API Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 98. Asia NSAID API Revenue by Region (2019-2024) & (US$ Million)

Table 99. Asia NSAID API Revenue by Region (2025-2030) & (US$ Million)

Table 100. Asia NSAID API Sales by Region (2019-2024) & (K MT)

Table 101. Asia NSAID API Sales by Region (2025-2030) & (K MT)

Table 102. Middle East, Africa and Latin America NSAID API Sales by Type (2019-2024) & (K MT)

Table 103. Middle East, Africa and Latin America NSAID API Sales by Type (2025-2030) & (K MT)

Table 104. Middle East, Africa and Latin America NSAID API Revenue by Type (2019-2024) & (US$ Million)

Table 105. Middle East, Africa and Latin America NSAID API Revenue by Type (2025-2030) & (US$ Million)

Table 106. Middle East, Africa and Latin America NSAID API Sales by Application (2019-2024) & (K MT)

Table 107. Middle East, Africa and Latin America NSAID API Sales by Application (2025-2030) & (K MT)

Table 108. Middle East, Africa and Latin America NSAID API Revenue by Application (2019-2024) & (US$ Million)

Table 109. Middle East, Africa and Latin America NSAID API Revenue by Application (2025-2030) & (US$ Million)

Table 110. Middle East, Africa and Latin America NSAID API Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 111. Middle East, Africa and Latin America NSAID API Revenue by Country (2019-2024) & (US$ Million)

Table 112. Middle East, Africa and Latin America NSAID API Revenue by Country (2025-2030) & (US$ Million)

Table 113. Middle East, Africa and Latin America NSAID API Sales by Country (2019-2024) & (K MT)

Table 114. Middle East, Africa and Latin America NSAID API Sales by Country (2025-2030) & (K MT)

Table 115. Novartis Company Information

Table 116. Novartis Description and Major Businesses

Table 117. Novartis NSAID API Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 118. Novartis NSAID API Product Model Numbers, Pictures, Descriptions and Specifications

Table 119. Novartis Recent Development

Table 120. Pfizer Company Information

Table 121. Pfizer Description and Major Businesses

Table 122. Pfizer NSAID API Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 123. Pfizer NSAID API Product Model Numbers, Pictures, Descriptions and Specifications

Table 124. Pfizer Recent Development

Table 125. Boehringer Ingelheim Company Information

Table 126. Boehringer Ingelheim Description and Major Businesses

Table 127. Boehringer Ingelheim NSAID API Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 128. Boehringer Ingelheim NSAID API Product Model Numbers, Pictures, Descriptions and Specifications

Table 129. Boehringer Ingelheim Recent Development

Table 130. Teva Pharmaceutical Company Information

Table 131. Teva Pharmaceutical Description and Major Businesses

Table 132. Teva Pharmaceutical NSAID API Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 133. Teva Pharmaceutical NSAID API Product Model Numbers, Pictures, Descriptions and Specifications

Table 134. Teva Pharmaceutical Recent Development

Table 135. BASF Company Information

Table 136. BASF Description and Major Businesses

Table 137. BASF NSAID API Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 138. BASF NSAID API Product Model Numbers, Pictures, Descriptions and Specifications

Table 139. BASF Recent Development

Table 140. Hospira Company Information

Table 141. Hospira Description and Major Businesses

Table 142. Hospira NSAID API Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 143. Hospira NSAID API Product Model Numbers, Pictures, Descriptions and Specifications

Table 144. Hospira Recent Development

Table 145. Lonza Group Company Information

Table 146. Lonza Group Description and Major Businesses

Table 147. Lonza Group NSAID API Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 148. Lonza Group NSAID API Product Model Numbers, Pictures, Descriptions and Specifications

Table 149. Lonza Group Recent Development

Table 150. Mylan Company Information

Table 151. Mylan Description and Major Businesses

Table 152. Mylan NSAID API Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 153. Mylan NSAID API Product Model Numbers, Pictures, Descriptions and Specifications

Table 154. Mylan Recent Development

Table 155. Aurobindo Pharma Company Information

Table 156. Aurobindo Pharma Description and Major Businesses

Table 157. Aurobindo Pharma NSAID API Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 158. Aurobindo Pharma NSAID API Product Model Numbers, Pictures, Descriptions and Specifications

Table 159. Aurobindo Pharma Recent Development

Table 160. Cambrex Company Information

Table 161. Cambrex Description and Major Businesses

Table 162. Cambrex NSAID API Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 163. Cambrex NSAID API Product Model Numbers, Pictures, Descriptions and Specifications

Table 164. Cambrex Recent Development

Table 165. Dr. Reddy's Laboratories Company Information

Table 166. Dr. Reddy's Laboratories Description and Major Businesses

Table 167. Dr. Reddy's Laboratories NSAID API Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 168. Dr. Reddy's Laboratories NSAID API Product Model Numbers, Pictures, Descriptions and Specifications

Table 169. Dr. Reddy's Laboratories Recent Development

Table 170. Actavis Company Information

Table 171. Actavis Description and Major Businesses

Table 172. Actavis NSAID API Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 173. Actavis NSAID API Product Model Numbers, Pictures, Descriptions and Specifications

Table 174. Actavis Recent Development

Table 175. Wuxi Apptec Company Information

Table 176. Wuxi Apptec Description and Major Businesses

Table 177. Wuxi Apptec NSAID API Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 178. Wuxi Apptec NSAID API Product Model Numbers, Pictures, Descriptions and Specifications

Table 179. Wuxi Apptec Recent Development

Table 180. Zhejiang NHU Company Information

Table 181. Zhejiang NHU Description and Major Businesses

Table 182. Zhejiang NHU NSAID API Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 183. Zhejiang NHU NSAID API Product Model Numbers, Pictures, Descriptions and Specifications

Table 184. Zhejiang NHU Recent Development

Table 185. Key Raw Materials Lists

Table 186. Raw Materials Key Suppliers Lists

Table 187. NSAID API Distributors List

Table 188. NSAID API Customers List

Table 189. NSAID API Market Trends

Table 190. NSAID API Market Drivers

Table 191. NSAID API Market Challenges

Table 192. NSAID API Market Restraints

Table 193. Research Programs/Design for This Report

Table 194. Key Data Information from Secondary Sources

Table 195. Key Data Information from Primary Sources

List of Figures

Figure 1. NSAID API Product Picture

Figure 2. Global NSAID API Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global NSAID API Market Share by Type in 2023 & 2030

Figure 4. Paracetamol Product Picture

Figure 5. Ibuprofen Product Picture

Figure 6. Aspirin Product Picture

Figure 7. Naproxen Product Picture

Figure 8. Others Product Picture

Figure 9. Global NSAID API Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 10. Global NSAID API Market Share by Application in 2023 & 2030

Figure 11. Captive Manufacturing

Figure 12. Contract Manufacturing

Figure 13. NSAID API Report Years Considered

Figure 14. Global NSAID API Capacity, Production and Utilization (2019-2030) & (K MT)

Figure 15. Global NSAID API Production Market Share by Region in Percentage: 2023 Versus 2030

Figure 16. Global NSAID API Production Market Share by Region (2019-2030)

Figure 17. NSAID API Production Growth Rate in North America (2019-2030) & (K MT)

Figure 18. NSAID API Production Growth Rate in Europe (2019-2030) & (K MT)

Figure 19. NSAID API Production Growth Rate in China (2019-2030) & (K MT)

Figure 20. NSAID API Production Growth Rate in Japan (2019-2030) & (K MT)

Figure 21. Global NSAID API Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 22. Global NSAID API Revenue 2019-2030 (US$ Million)

Figure 23. Global NSAID API Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 24. Global NSAID API Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 25. Global NSAID API Revenue Market Share by Region (2019-2030)

Figure 26. Global NSAID API Sales 2019-2030 ((K MT)

Figure 27. Global NSAID API Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K MT)

Figure 28. Global NSAID API Sales Market Share by Region (2019-2030)

Figure 29. US & Canada NSAID API Sales YoY (2019-2030) & (K MT)

Figure 30. US & Canada NSAID API Revenue YoY (2019-2030) & (US$ Million)

Figure 31. Europe NSAID API Sales YoY (2019-2030) & (K MT)

Figure 32. Europe NSAID API Revenue YoY (2019-2030) & (US$ Million)

Figure 33. China NSAID API Sales YoY (2019-2030) & (K MT)

Figure 34. China NSAID API Revenue YoY (2019-2030) & (US$ Million)

Figure 35. Asia (excluding China) NSAID API Sales YoY (2019-2030) & (K MT)

Figure 36. Asia (excluding China) NSAID API Revenue YoY (2019-2030) & (US$ Million)

Figure 37. Middle East, Africa and Latin America NSAID API Sales YoY (2019-2030) & (K MT)

Figure 38. Middle East, Africa and Latin America NSAID API Revenue YoY (2019-2030) & (US$ Million)

Figure 39. The NSAID API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 40. The Top 5 and 10 Largest Manufacturers of NSAID API in the World: Market Share by NSAID API Revenue in 2023

Figure 41. Global NSAID API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 42. Global NSAID API Sales Market Share by Type (2019-2030)

Figure 43. Global NSAID API Revenue Market Share by Type (2019-2030)

Figure 44. Global NSAID API Sales Market Share by Application (2019-2030)

Figure 45. Global NSAID API Revenue Market Share by Application (2019-2030)

Figure 46. US & Canada NSAID API Sales Market Share by Type (2019-2030)

Figure 47. US & Canada NSAID API Revenue Market Share by Type (2019-2030)

Figure 48. US & Canada NSAID API Sales Market Share by Application (2019-2030)

Figure 49. US & Canada NSAID API Revenue Market Share by Application (2019-2030)

Figure 50. US & Canada NSAID API Revenue Share by Country (2019-2030)

Figure 51. US & Canada NSAID API Sales Share by Country (2019-2030)

Figure 52. U.S. NSAID API Revenue (2019-2030) & (US$ Million)

Figure 53. Canada NSAID API Revenue (2019-2030) & (US$ Million)

Figure 54. Europe NSAID API Sales Market Share by Type (2019-2030)

Figure 55. Europe NSAID API Revenue Market Share by Type (2019-2030)

Figure 56. Europe NSAID API Sales Market Share by Application (2019-2030)

Figure 57. Europe NSAID API Revenue Market Share by Application (2019-2030)

Figure 58. Europe NSAID API Revenue Share by Country (2019-2030)

Figure 59. Europe NSAID API Sales Share by Country (2019-2030)

Figure 60. Germany NSAID API Revenue (2019-2030) & (US$ Million)

Figure 61. France NSAID API Revenue (2019-2030) & (US$ Million)

Figure 62. U.K. NSAID API Revenue (2019-2030) & (US$ Million)

Figure 63. Italy NSAID API Revenue (2019-2030) & (US$ Million)

Figure 64. Russia NSAID API Revenue (2019-2030) & (US$ Million)

Figure 65. China NSAID API Sales Market Share by Type (2019-2030)

Figure 66. China NSAID API Revenue Market Share by Type (2019-2030)

Figure 67. China NSAID API Sales Market Share by Application (2019-2030)

Figure 68. China NSAID API Revenue Market Share by Application (2019-2030)

Figure 69. Asia NSAID API Sales Market Share by Type (2019-2030)

Figure 70. Asia NSAID API Revenue Market Share by Type (2019-2030)

Figure 71. Asia NSAID API Sales Market Share by Application (2019-2030)

Figure 72. Asia NSAID API Revenue Market Share by Application (2019-2030)

Figure 73. Asia NSAID API Revenue Share by Region (2019-2030)

Figure 74. Asia NSAID API Sales Share by Region (2019-2030)

Figure 75. Japan NSAID API Revenue (2019-2030) & (US$ Million)

Figure 76. South Korea NSAID API Revenue (2019-2030) & (US$ Million)

Figure 77. China Taiwan NSAID API Revenue (2019-2030) & (US$ Million)

Figure 78. Southeast Asia NSAID API Revenue (2019-2030) & (US$ Million)

Figure 79. India NSAID API Revenue (2019-2030) & (US$ Million)

Figure 80. Middle East, Africa and Latin America NSAID API Sales Market Share by Type (2019-2030)

Figure 81. Middle East, Africa and Latin America NSAID API Revenue Market Share by Type (2019-2030)

Figure 82. Middle East, Africa and Latin America NSAID API Sales Market Share by Application (2019-2030)

Figure 83. Middle East, Africa and Latin America NSAID API Revenue Market Share by Application (2019-2030)

Figure 84. Middle East, Africa and Latin America NSAID API Revenue Share by Country (2019-2030)

Figure 85. Middle East, Africa and Latin America NSAID API Sales Share by Country (2019-2030)

Figure 86. Brazil NSAID API Revenue (2019-2030) & (US$ Million)

Figure 87. Mexico NSAID API Revenue (2019-2030) & (US$ Million)

Figure 88. Turkey NSAID API Revenue (2019-2030) & (US$ Million)

Figure 89. Israel NSAID API Revenue (2019-2030) & (US$ Million)

Figure 90. GCC Countries NSAID API Revenue (2019-2030) & (US$ Million)

Figure 91. NSAID API Value Chain

Figure 92. NSAID API Production Process

Figure 93. Channels of Distribution

Figure 94. Distributors Profiles

Figure 95. Bottom-up and Top-down Approaches for This Report

Figure 96. Data Triangulation

Figure 97. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global NSAID API market? zhanKai

The top companies in the global NSAID API market are Novartis、Pfizer、Boehringer Ingelheim.

Related Reports

NSAID API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for NSAID API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-15
Pages: 141
USD 3950.00
(Single User License)
Global NSAID API Market Research Report 2026
The global NSAID API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-28
Pages: 136
USD 2900.00
(Single User License)
Global NSAID API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global NSAID API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 158
USD 4900.00
(Single User License)
Global NSAID API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global NSAID API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 91
USD 4250.00
(Single User License)
Global NSAID API Market Research Report 2025
The global market for NSAID API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-24
Pages: 101
USD 2900.00
(Single User License)
NSAID API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for NSAID API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 119
USD 3950.00
(Single User License)
Global NSAID API Market Research Report 2024
Active pharmaceutical ingredients (APIs) are bulk drug products that are used as raw materials for formulations. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that groups together drugs that provide analgesic (pain-killing) and antipyretic (fever-reducing) effects, and, in higher doses, anti-inflammatory effects.
Published Date: 2024-01-16
Pages: 101
USD 2900.00
(Single User License)

NSAID API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for NSAID API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-15
Pages: 141
USD 3950.00 (Single User License)
Global NSAID API Market Research Report 2026
The global NSAID API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-28
Pages: 136
USD 2900.00 (Single User License)
Global NSAID API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global NSAID API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 158
USD 4900.00 (Single User License)
Global NSAID API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global NSAID API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 91
USD 4250.00 (Single User License)
Global NSAID API Market Research Report 2025
The global market for NSAID API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-24
Pages: 101
USD 2900.00 (Single User License)
NSAID API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for NSAID API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 119
USD 3950.00 (Single User License)
Global NSAID API Market Research Report 2024
Active pharmaceutical ingredients (APIs) are bulk drug products that are used as raw materials for formulations. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that groups together drugs that provide analgesic (pain-killing) and antipyretic (fever-reducing) effects, and, in higher doses, anti-inflammatory effects.
Published: 2024-01-16
Pages: 101
USD 2900.00 (Single User License)